NUCLEOLIN and cancer: The aptamer, a transport agent for cell-surface nucleolin-expressing cancer cells, significantly improved degrader uptake and internalization in nucleolin-overexpressing MCF-7 cells, leading to high efficiency in vivo BRD4 degradation and antitumor potency as well as decreased toxicity.